Sarah Linklater is acting Editor-in-Chief of The Lancet Diabetes & Endocrinology. After a short period working in industry, Sarah obtained a PhD in Experimental Medicine for studies in autoimmunity and human regulatory T cells at the University of British Columbia in Vancouver, Canada, and at the Hospital San Raffaele in Milan, Italy. In 2008, Sarah moved to the UK to pursue a career in scientific publishing, first as an editor with Nature Publishing Group in London and later with The Company of Biologists in Cambridge. She joined The Lancet group in early 2013 to help launch The Lancet Diabetes & Endocrinology. She is based in London, UK.